PTC Therapeutics (PTCT) Receives a Hold from Barclays
In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a ...
PTC Therapeutics Reports Strong Q3 2024 Performance
PTC Therapeutics ( (PTCT) ) has released its Q3 earnings. Here is a breakdown of the information PTC Therapeutics presented to its investors.